| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |